Zhenxue Deng

Title: Zhenxue Deng: Innovator in Pharmaceutical Composition

Introduction

Zhenxue Deng is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for cancer treatment. His work exemplifies the intersection of science and practical application in medicine.

Latest Patents

Zhenxue Deng holds a patent for a pharmaceutical composition of a MEK inhibitor and its preparation method. The patent describes a composition that includes 6-(2-chloro-4-iodophenylamino)-N-(2-hydroxyethoxy)-5-methyl-4-oxo-4,5-dihydrofuro[3,2-c]pyridine-7-carboxamide or a pharmaceutically acceptable salt, along with a binder, a surface stabilizer, and a dispersant. This composition can be dispersed in water to form a pharmaceutical suspension with a median particle size, X50, ranging from 0.5 µm to 4.0 µm. The invention is aimed at providing effective treatment options for various cancers.

Career Highlights

Zhenxue Deng is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research and development efforts. His work has led to the creation of innovative pharmaceutical solutions that address critical health challenges.

Collaborations

Zhenxue Deng collaborates with talented professionals in his field, including Jiahui Cai and Jiao Xu. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.

Conclusion

Zhenxue Deng's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for cancer. His patent and ongoing work at Chia Tai Tianqing Pharmaceutical Group Co., Ltd. reflect his commitment to improving healthcare through scientific advancement.